0001833214 2021-01-01 2021-06-30 0001833214 2021-06-30 0001833214 2020-12-31 0001833214 2021-04-01 2021-06-30 0001833214 us-gaap:CommonStockMember 2020-12-31 0001833214 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001833214 us-gaap:RetainedEarningsMember 2020-12-31 0001833214 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001833214 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001833214 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001833214 2021-01-01 2021-03-31 0001833214 us-gaap:CommonStockMember 2021-03-31 0001833214 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001833214 us-gaap:RetainedEarningsMember 2021-03-31 0001833214 2021-03-31 0001833214 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001833214 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001833214 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001833214 us-gaap:CommonStockMember 2021-06-30 0001833214 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001833214 us-gaap:RetainedEarningsMember 2021-06-30 0001833214 us-gaap:IPOMember 2021-01-13 2021-01-14 0001833214 us-gaap:OverAllotmentOptionMember 2021-01-13 2021-01-14 0001833214 us-gaap:IPOMember 2021-01-14 0001833214 us-gaap:CommonStockMember 2021-01-14 0001833214 BCYP:ClosingIPOMember BCYP:SponsorMember 2021-01-13 2021-01-14 0001833214 BCYP:ClosingIPOMember BCYP:SponsorMember 2021-01-14 0001833214 us-gaap:IPOMember 2021-01-01 2021-06-30 0001833214 us-gaap:IPOMember 2021-06-30 0001833214 us-gaap:WarrantMember 2021-01-01 2021-06-30 0001833214 srt:MaximumMember 2021-01-14 0001833214 2021-01-13 2021-01-14 0001833214 us-gaap:OverAllotmentOptionMember 2021-01-14 0001833214 BCYP:BusinessCombinationAgreementMember 2021-06-21 0001833214 BCYP:BusinessCombinationAgreementMember 2021-06-20 2021-06-21 0001833214 2021-06-20 2021-06-21 0001833214 BCYP:PublicAndPrivateWarrantsMember 2021-01-13 2021-01-14 0001833214 srt:ScenarioPreviouslyReportedMember 2021-01-14 0001833214 srt:RestatementAdjustmentMember 2021-01-14 0001833214 2021-01-14 0001833214 us-gaap:CommonClassAMember 2021-01-14 0001833214 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2021-01-01 2021-06-30 0001833214 BCYP:ClosingIPOMember BCYP:SponsorMember 2021-01-01 2021-06-30 0001833214 BCYP:ClosingIPOMember BCYP:SponsorMember 2021-06-30 0001833214 BCYP:SponsorMember BCYP:FounderSharesMember 2020-11-10 2020-11-13 0001833214 BCYP:SponsorMember BCYP:FounderSharesMember 2020-11-13 0001833214 BCYP:SponsorMember BCYP:FounderSharesMember 2020-12-06 2020-12-07 0001833214 BCYP:LadenburgAndCertainEmployeesMember BCYP:RepresentativeSharesMember 2020-12-06 2020-12-07 0001833214 BCYP:LadenburgAndCertainEmployeesMember BCYP:RepresentativeSharesMember 2020-12-07 0001833214 BCYP:FounderSharesMember 2021-01-03 0001833214 BCYP:FounderSharesMember 2021-01-02 2021-01-03 0001833214 BCYP:FounderSharesMember us-gaap:OverAllotmentOptionMember 2021-01-13 2021-01-14 0001833214 BCYP:SponsorMember BCYP:FounderSharesMember 2021-01-02 2021-01-04 0001833214 BCYP:LadenburgAndCertainEmployeesMember BCYP:RepresentativeSharesMember 2021-01-02 2021-01-04 0001833214 BCYP:SponsorMember BCYP:FounderSharesMember 2021-01-01 2021-01-04 0001833214 BCYP:SponsorMember BCYP:FounderSharesMember 2021-12-06 2021-12-07 0001833214 BCYP:LadenburgAndCertainEmployeesMember BCYP:RepresentativeSharesMember 2021-12-06 2021-12-07 0001833214 BCYP:LadenburgAndCertainEmployeesMember BCYP:RepresentativeSharesMember 2021-12-07 0001833214 BCYP:LadenburgAndCertainEmployeesMember BCYP:RepresentativeSharesMember 2021-01-04 0001833214 BCYP:LadenburgAndCertainEmployeesMember BCYP:RepresentativeSharesMember 2021-01-02 2021-01-03 0001833214 srt:MaximumMember BCYP:SponsorMember 2020-11-19 0001833214 BCYP:SponsorMember 2020-11-18 2020-11-19 0001833214 2021-01-10 2021-01-14 0001833214 BCYP:SponsorMember 2021-01-01 2021-06-30 0001833214 us-gaap:OverAllotmentOptionMember BCYP:UnderwritingAgreementMember 2021-01-13 2021-01-14 0001833214 BCYP:UnderwritersMember us-gaap:IPOMember 2021-01-13 2021-01-14 0001833214 2020-01-01 2020-12-31 0001833214 us-gaap:FairValueInputsLevel1Member 2021-06-30 0001833214 us-gaap:FairValueInputsLevel2Member 2021-06-30 0001833214 us-gaap:FairValueInputsLevel3Member 2021-06-30 0001833214 BCYP:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001833214 BCYP:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001833214 BCYP:WarrantsLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001833214 BCYP:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-06-30 0001833214 BCYP:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-06-30 0001833214 BCYP:WarrantsLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2021-01-01 2021-06-30 0001833214 BCYP:PrivatePlacementWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001833214 BCYP:PublicWarrantsMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001833214 BCYP:WarrantsLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2021-06-30 0001833214 srt:MaximumMember BCYP:SponsorMember 2020-11-12 2020-12-31 0001833214 srt:MaximumMember BCYP:LadenburgAndCertainEmployeesMember 2020-11-12 2020-12-31 0001833214 2020-11-12 2020-12-31 0001833214 us-gaap:CommonStockMember 2020-11-11 0001833214 us-gaap:AdditionalPaidInCapitalMember 2020-11-11 0001833214 us-gaap:RetainedEarningsMember 2020-11-11 0001833214 2020-11-11 0001833214 us-gaap:CommonStockMember 2020-11-12 2020-12-31 0001833214 us-gaap:AdditionalPaidInCapitalMember 2020-11-12 2020-12-31 0001833214 us-gaap:RetainedEarningsMember 2020-11-12 2020-12-31 0001833214 BCYP:SponsorMember 2020-11-12 2020-12-31 0001833214 BCYP:ClosingIPOMember BCYP:SponsorMember 2020-11-12 2020-12-31 0001833214 BCYP:ClosingIPOMember BCYP:SponsorMember 2020-12-31 0001833214 BCYP:SponsorMember 2020-11-17 2020-11-19 0001833214 2020-11-18 2020-11-20 0001833214 2020-11-20 0001833214 BCYP:SponsorMember BCYP:FounderSharesMember 2020-12-06 2020-12-07 0001833214 BCYP:LadenburgAndCertainEmployeesMember BCYP:RepresentativeSharesMember 2020-12-06 2020-12-07 0001833214 BCYP:LadenburgAndCertainEmployeesMember BCYP:RepresentativeSharesMember 2020-12-07 0001833214 BCYP:SponsorMember 2021-01-04 0001833214 BCYP:SponsorMember 2021-01-02 2021-01-04 0001833214 BCYP:LadenburgAndCertainEmployeesMember 2021-01-02 2021-01-04 0001833214 2021-01-02 2021-01-04 0001833214 us-gaap:WarrantMember 2020-11-12 2020-12-31 iso4217:USD shares iso4217:USD shares pure 0001833214 false

S-4 Big Cypress Acquisition Corp. DE 85-3899721 300 W. 41st Street Suite 202 Miami Beach FL 33140 (305) 204-3338 Non-accelerated Filer true true false

756803

84836

179867

2258

936670

87094

235111

116155315

117091985

322205

152879

156201

150000

152879

306201

-4220500

5531106

9904485

306201

10117574

102187499

0.0001

1000000

0.0001

50000000

4674626

2875000

10117574

467

288

4237471

24712

762063

-8996

5000001

16004

117091985

322205

256847

368459

-256847

-368459

2896

5315

-359874

1948210

-1494077

-1945314

1139518

-2202161

771059

4443103

4162957

-0.50

0.18

10117574

2875000

288

24712

-8996

16004

11500000

1150

109250365

109251515

417200 417200 42 4171958 4172000 2105 2105

7025183

-10117574

-1035

-104388621

-104389656

2973220

4456591

445

2035336

2964224

5000005

4456591

445

2035336

2964224

5000005

-2202161

218035

2202135

2202157

218035

2202135

2202157

4674626

467

4237471

762063

5000001

4674626

467

4237471

762063

5000001

771059

5315 -359874

-1494077

177609

81657

-464411

116150000

-116150000

113470500

4172000

-2105

150000

208227

117286378

671967

84836

756803

101131827

1055672 7025183 4220500 84979

<p id="xdx_805_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zYKCPxbHGkgb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note 1 — Organization and Business Operations Big Cypress Acquisition Corp. (the “Company”) is a newly organized blank check company incorporated in Delaware on November 12, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). As of June 30, 2021, the Company had not commenced any operations. All activity through June 30, 2021 relates to the Company’s formation and the Initial Public Offering (“IPO”) which is described below, and identifying a target company for a Business Combination. The Company will not generate any operating revenues until after the completion of a Business Combination, at the earliest. The Company generates non-operating income in the form of interest income from the proceeds derived from the Initial Public Offering and income/expense from change in fair value of warrant liability. The registration statement for the Company’s IPO was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on January 11, 2021 (the “Effective Date”). On January 14, 2021, the Company consummated the IPO of <span id="xdx_90E_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zcdcjPDsaNvk" title="Units issued during the period, shares">11,500,000 units (the “Units”) and, with respect to the shares of common stock included in the Units sold (the “Public Shares”), which included the full exercise by the underwriters of the over-allotment option to purchase an additional <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_znJ3tAxtO8z6" title="Units issued during the period, shares">1,500,000 Units, at $10.00 per Unit, generating gross proceeds of $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zfq78Vd1olDh" title="Proceeds from IPO">115,000,000, which is discussed in Note 4. Each Unit consists of one share of common stock, and one-half redeemable warrant to purchase one share of common stock at a price of $11.50 per whole share. Simultaneously with the closing of the IPO, the Company consummated the sale of <span id="xdx_904_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20210113__20210114__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_zvEF6attdnCe" title="Sale of units">417,200 units (the “Placement Units”), at a price of $<span id="xdx_908_eus-gaap--SharesIssuedPricePerShare_iI_pid_c20210114__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_z7MoIBDJI2Bj" title="Unit issued price">10.00 per unit, in a private placement to Big Cypress Holdings LLC (the “Sponsor”), generating gross proceeds of $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pip0_c20210113__20210114__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_zZDUKWQTr5J2" title="Proceeds from sale of units">4,172,000, which is discussed in Note 5. Transaction costs of the IPO amounted to $6,108,360 consisting of $1,529,500 of underwriting fee, $4,220,500 of deferred underwriting fee, and $358,360 of other offering costs, and of which $359,874 were allocated to expense associated with the warrant liability. Following the closing of the IPO on January 14, 2021, $116,150,000 ($10.10 per Unit) from the net offering proceeds of the sale of the Units in the IPO and the sale of the Placement Units was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its franchise and income tax obligations (less up to $100,000 of interest to pay dissolution expenses), the proceeds from this IPO and the sale of the Placement Units will not be released from the trust account until the earliest of (a) the completion of the Company’s initial business combination, (b) the redemption of any public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation, and (c) the redemption of the Company’s public shares if the Company is unable to complete the initial business combination within 15 months (or up to 21 months) from the closing of this IPO, subject to applicable law. The proceeds deposited in the trust account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders. The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the initial business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially approximately $10.10 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The Company will have 15 months (or up to 21 months) from the closing of the IPO on January 14, 2021 to consummate a Business Combination (the “Combination Period”). However, if the Company is unable to complete a Business Combination within the Combination Period,the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the trust account, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company to pay its franchise and income taxes, divided by the number of then outstanding public shares, subject to applicable law and as further described in the registration statement, and then seek to dissolve and liquidate. The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their founder shares and placement shares in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to their founder shares and placement shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the trust account with respect to their founder shares and placement shares if the Company fails to complete the initial business combination within the Combination Period. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believes that the Company’s Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations. Risks and Uncertainties Management is continuing to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that it could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. Business Combination Agreement On June 21, 2021, the Company, entered into a business combination agreement (the “Business Combination Agreement”) by and among the Company, Big Cypress Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“Merger Sub”) SAB Biotherapeutics, Inc., a Delaware corporation (“SAB”) and Shareholder Representative Services LLC, as the stockholder representative to the SAB stockholders. The Business Combination Agreement provides, among other things, that on the terms and subject to the conditions set forth therein, Merger Sub will merge with and into SAB, with SAB surviving as a wholly-owned subsidiary of the Company (the “Merger”). Upon the closing of the Business Combination (the “Closing”), it is anticipated that the Company will change its name to “SAB Biotherapeutics, Inc.” (“New SAB”). The Merger and the other transactions contemplated by the Business Combination Agreement are hereinafter referred to as the “Business Combination.” The Business Combination is expected to close in the fourth quarter of 2021, following the receipt of the required approval by the Company’s stockholders and the fulfilment of other customary closing conditions. In accordance with the terms and subject to the conditions of the Business Combination Agreement, prior to the effective time of the Merger (the “Effective Time”) the outstanding preferred stock of SAB will convert into common stock and at the Effective Time, (i) the outstanding common (including the converted preferred stock) of SAB (collectively, the “SAB Shares”) will be automatically cancelled, extinguished and converted into a number of the Company’s common stock, par value $0.0001 per share (the “Company New Shares”), based on SAB’s equity value; (ii) each outstanding vested and unvested option to purchase SAB Shares will be canceled in exchange for a comparable option to purchase Company New Shares, based on SAB’s equity value with respect to the vested options; and (iii) each unvested award of restricted SAB Shares will be converted into a comparable right to receive restricted Company Shares, based on SAB’s equity value, in each of the foregoing cases, allocated in the manner described in the Business Combination Agreement. For purposes of the Business Combination Agreement, SAB’s equity value is $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pn5n6_c20210620__20210621__us-gaap--TypeOfArrangementAxis__custom--BusinessCombinationAgreementMember_zSRPiKfldI5j" title="Common stock value">300.0 million. In addition to the foregoing consideration, SAB stockholders shall be entitled to receive, as additional consideration, and without any action on behalf of the Company, Merger Sub, or the Company’s stockholders, approximately ____ additional Company New Shares (the “Earnout Shares”), to be issued at the effective time and held in an Earnout Escrow Account as follows during the period from and after the Closing until the fifth anniversary of the Closing (the “Earnout Period”) (A) 25% of the Earnout Shares, if the VWAP (as defined in the Business Combination Agreement) of Company Shares is greater than or equal to $15.00 for any twenty (20) Trading Days (as defined in the Business Combination Agreement) within a period of thirty (30) consecutive Trading Days, (B) 25% of the Earnout Shares, if the VWAP of Company Shares is greater than or equal to $20.00 for any twenty (20) Trading Days within a period of thirty (30) consecutive Trading Days, (C) 25% of the Earnout Shares, if the VWAP of Company Shares is greater than or equal to $25.00 for any twenty (20) Trading Days within a period of thirty (30) consecutive Trading Days, and (D) 25% of the Earnout Shares, if the VWAP of Company Shares is greater than or equal to $30.00 for any twenty (20) Trading Days within a period of thirty (30) consecutive Trading Days. During the Earnout Period, if New SAB experiences a Change of Control (as defined as defined in the Business Combination Agreement), then each tranche of Earnout Shares will also be earned and released to the SAB stockholders in the event that such Change of Control results in the holders of New SAB Biotherapeutics Common Stock receiving per-share aggregate consideration equal to or in excess of the applicable tranche of Earnout Shares. The Business Combination Agreement may be terminated under certain customary and limited circumstances described in the Business Combination Agreement, including, without limitation, each party’s right to terminate, subject to certain limited exceptions, if the Business Combination is not consummated by December 15, 2021. If the Business Combination Agreement is validly terminated, none of the parties to the Business Combination Agreement will have any liability with respect to the other parties to the Business Combination Agreement or any further obligation under the Business Combination Agreement, other than customary confidentiality obligations, except in the case of Willful Breach or Fraud (each, as defined in the Business Combination Agreement).

11500000

1500000

10.00

115000000

Each Unit consists of one share of common stock, and one-half redeemable warrant to purchase one share of common stock at a price of $11.50 per whole share.

11.50

417200

10.00

4172000

6108360

1529500

4220500

358360

359874

116150000

100000

10.10 The Company will have 15 months (or up to 21 months) from the closing of the IPO on January 14, 2021 to consummate a Business Combination (the “Combination Period”). However, if the Company is unable to complete a Business Combination within the Combination Period,the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the trust account, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company to pay its franchise and income taxes, divided by the number of then outstanding public shares, subject to applicable law and as further described in the registration statement, and then seek to dissolve and liquidate. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $

10.00

0.0001

300000000.0

(A) 25% of the Earnout Shares, if the VWAP (as defined in the Business Combination Agreement) of Company Shares is greater than or equal to $15.00 for any twenty (20) Trading Days (as defined in the Business Combination Agreement) within a period of thirty (30) consecutive Trading Days, (B) 25% of the Earnout Shares, if the VWAP of Company Shares is greater than or equal to $20.00 for any twenty (20) Trading Days within a period of thirty (30) consecutive Trading Days, (C) 25% of the Earnout Shares, if the VWAP of Company Shares is greater than or equal to $25.00 for any twenty (20) Trading Days within a period of thirty (30) consecutive Trading Days, and (D) 25% of the Earnout Shares, if the VWAP of Company Shares is greater than or equal to $30.00 for any twenty (20) Trading Days within a period of thirty (30) consecutive Trading Days.

Note 2 — Restatement of Previously Issued Financial Statements In April 2021, the Company concluded that, because of a misapplication of the accounting guidance related to its Public and Private Placement warrants the Company issued in January 2021, the Company’s previously issued balance sheet as of January 14, 2021 on Form 8-K filed with SEC on January 21, 2021 should no longer be relied upon. As such, the Company restated its balance sheet included in that Form 8-K as shown below. On April 12, 2021, the staff of the Securities and Exchange Commission (the “SEC Staff”) issued a public statement entitled “Staff Statement on Accounting and Reporting Considerations for Warrants issued by Special Purpose Acquisition Companies (“SPACs”)” (the “SEC Staff Statement”). In the SEC Staff Statement, the SEC Staff expressed its view that certain terms and conditions common to SPAC warrants may require the warrants to be classified as liabilities on the SPAC’s balance sheet as opposed to equity. Since issuance on January 14, 2021, the Company’s warrants were accounted for as equity within the Company’s previously reported balance sheet, and after discussion and evaluation, management, in consultation with its Audit Committee, concluded that the warrants should be presented as liabilities with subsequent fair value remeasurement. Historically, the Warrants were reflected as a component of equity as opposed to liabilities on the balance sheets and the statements of operations did not include the subsequent non-cash changes in estimated fair value of the Warrants, based on our application of FASB ASC Topic 815-40, Derivatives and Hedging, Contracts in Entity’s Own Equity (“ASC 815-40). The views expressed in the SEC Staff Statement were not consistent with the Company’s historical interpretation of the specific provisions within its warrant agreement and the Company’s application of ASC 815-40 to the warrant agreement. The Company reassessed its accounting for Warrants issued on January 14, 2021, in light of the SEC Staff’s published views. Based on this reassessment, management determined that the Warrants should be classified as liabilities measured at fair value upon issuance, with subsequent changes in fair value reported in the Company Statement of Operations each reporting period. Impact of the Restatement The impact to the balance sheet dated January 14, 2021, filed on Form 8-K on January 21, 2021 related to the impact of accounting for public and private warrants as liabilities at fair value resulted in a $<span id="xdx_90A_eus-gaap--FairValueAdjustmentOfWarrants_pn5n6_c20210113__20210114__us-gaap--StatementClassOfStockAxis__custom--PublicAndPrivateWarrantsMember_zHwmOHvmvuy" title="Change in fair value of warrant liabilities">7.0 million increase to the warrant liabilities line item on January 14, 2021 and offsetting decrease to the Class A common stock subject to redemption mezzanine equity line item. Transaction costs of the IPO of $<span id="xdx_90C_eus-gaap--SaleOfStockConsiderationReceivedPerTransaction_pp0p0_c20210113__20210114__us-gaap--StatementClassOfStockAxis__custom--PublicAndPrivateWarrantsMember_zvmaY4Kt5nH1" title="IPO Transaction costs">355,750 were allocated to expense associated with the warrant liability, which is reflected in the change to the accumulated deficit line. There is no change to total stockholders’ equity at any reported balance sheet date. Schedule of Restatement of Balance Sheet <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of January 14, 2021</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As Previously Reported</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Restatement Adjustment</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As Restated</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Balance Sheet as of January 14, 2021</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 47%; text-align: left; padding-bottom: 2.5pt">Total assets</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_989_eus-gaap--Assets_iI_pp0p0_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zt0le64r3Awc" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Total assets">117,645,054</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_984_eus-gaap--Assets_iI_pp0p0_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_zgX7AivKBFHd" style="border-bottom: Black 2.5pt double; width: 14%; text-align: right" title="Total assets">—</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_986_eus-gaap--Assets_iI_pp0p0_c20210114_zTw8teAyMXi9" style="border-bottom: Black 2.5pt double; width: 14%; text-align: right" title="Total assets">117,645,045</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Liabilities and stockholders’ equity</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total current liabilities</td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_984_eus-gaap--LiabilitiesCurrent_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Total current liabilities">267,540</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_985_eus-gaap--LiabilitiesCurrent_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Total current liabilities">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98A_eus-gaap--LiabilitiesCurrent_c20210114_pp0p0" style="text-align: right" title="Total current liabilities">267,540</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Stock warrant liabilities</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_989_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock warrant liabilities">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_984_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock warrant liabilities">7,025,183</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210114_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock warrant liabilities">7,025,183</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total liabilities</td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98A_eus-gaap--Liabilities_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Total liabilities">4,488,040</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--Liabilities_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Total liabilities">7,025,183</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_989_eus-gaap--Liabilities_c20210114_pp0p0" style="text-align: right" title="Total liabilities">11,513,223</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Class A common stock, $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210114__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOJayqxITnqc" title="Common stock, par value">0.0001 par value; shares subject to possible redemption</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityRedemptionValue_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Class A common stock, $0.0001 par value; shares subject to possible redemption">108,157,010</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--RedeemableNoncontrollingInterestEquityRedemptionValue_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Class A common stock, $0.0001 par value; shares subject to possible redemption">(7,025,183</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98D_eus-gaap--RedeemableNoncontrollingInterestEquityRedemptionValue_c20210114_pp0p0" style="text-align: right" title="Class A common stock, $0.0001 par value; shares subject to possible redemption">101,131,827</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stockholders’ equity</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Preferred stock- $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210114_zNyRUJXeXNnk" title="Preferred stock, par value">0.0001 par value</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_eus-gaap--PreferredStockValue_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Preferred stock- $0.0001 par value">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98D_eus-gaap--PreferredStockValue_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Preferred stock- $0.0001 par value">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--PreferredStockValue_c20210114_pp0p0" style="text-align: right" title="Preferred stock- $0.0001 par value">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Common stock - $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210114_zPAUQXQrv5Mh" title="Common stock, par value">0.0001 par value</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_985_eus-gaap--CommonStockValue_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Common stock - $0.0001 par value">398</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--CommonStockValue_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Common stock - $0.0001 par value">81</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_987_eus-gaap--CommonStockValue_c20210114_pp0p0" style="text-align: right" title="Common stock - $0.0001 par value">479</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Additional paid-in-capital</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_989_eus-gaap--AdditionalPaidInCapital_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Additional paid-in-capital">5,003,838</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--AdditionalPaidInCapital_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Additional paid-in-capital">355,669</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--AdditionalPaidInCapital_c20210114_pp0p0" style="text-align: right" title="Additional paid-in-capital">5,359,507</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Accumulated deficit</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_986_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated deficit">(4,232</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated deficit">(355,750</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_980_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210114_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated deficit">(359,982</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total stockholders’ equity</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98B_eus-gaap--StockholdersEquity_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total stockholders' equity">5,000,004</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_988_eus-gaap--StockholdersEquity_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total stockholders' equity">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_987_eus-gaap--StockholdersEquity_c20210114_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total stockholders' equity">5,000,004</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders’ equity</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_989_eus-gaap--LiabilitiesAndStockholdersEquity_iI_pp0p0_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKMRLNTWoI64" style="border-bottom: Black 2.5pt double; text-align: right" title="Total liabilities and stockholders' equity">117,645,054</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98B_eus-gaap--LiabilitiesAndStockholdersEquity_iI_pp0p0_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_zn1QSTlxRoO4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total liabilities and stockholders' equity">—</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98C_eus-gaap--LiabilitiesAndStockholdersEquity_iI_pp0p0_c20210114_zpiQ9JOo06x1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total liabilities and stockholders' equity">117,645,054</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

7000000.0

355750

Schedule of Restatement of Balance Sheet <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As of January 14, 2021</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As Previously Reported</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Restatement Adjustment</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">As Restated</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Balance Sheet as of January 14, 2021</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 47%; text-align: left; padding-bottom: 2.5pt">Total assets</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_989_eus-gaap--Assets_iI_pp0p0_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zt0le64r3Awc" style="border-bottom: Black 2.5pt double; width: 16%; text-align: right" title="Total assets">117,645,054</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_984_eus-gaap--Assets_iI_pp0p0_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_zgX7AivKBFHd" style="border-bottom: Black 2.5pt double; width: 14%; text-align: right" title="Total assets">—</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_986_eus-gaap--Assets_iI_pp0p0_c20210114_zTw8teAyMXi9" style="border-bottom: Black 2.5pt double; width: 14%; text-align: right" title="Total assets">117,645,045</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Liabilities and stockholders’ equity</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total current liabilities</td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_984_eus-gaap--LiabilitiesCurrent_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Total current liabilities">267,540</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_985_eus-gaap--LiabilitiesCurrent_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Total current liabilities">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98A_eus-gaap--LiabilitiesCurrent_c20210114_pp0p0" style="text-align: right" title="Total current liabilities">267,540</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Stock warrant liabilities</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_989_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock warrant liabilities">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_984_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock warrant liabilities">7,025,183</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_987_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210114_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Stock warrant liabilities">7,025,183</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Total liabilities</td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98A_eus-gaap--Liabilities_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Total liabilities">4,488,040</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--Liabilities_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Total liabilities">7,025,183</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_989_eus-gaap--Liabilities_c20210114_pp0p0" style="text-align: right" title="Total liabilities">11,513,223</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Class A common stock, $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_900_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210114__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zOJayqxITnqc" title="Common stock, par value">0.0001 par value; shares subject to possible redemption</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_983_eus-gaap--RedeemableNoncontrollingInterestEquityRedemptionValue_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Class A common stock, $0.0001 par value; shares subject to possible redemption">108,157,010</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--RedeemableNoncontrollingInterestEquityRedemptionValue_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Class A common stock, $0.0001 par value; shares subject to possible redemption">(7,025,183</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98D_eus-gaap--RedeemableNoncontrollingInterestEquityRedemptionValue_c20210114_pp0p0" style="text-align: right" title="Class A common stock, $0.0001 par value; shares subject to possible redemption">101,131,827</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Stockholders’ equity</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt">Preferred stock- $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90D_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_pid_c20210114_zNyRUJXeXNnk" title="Preferred stock, par value">0.0001 par value</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_980_eus-gaap--PreferredStockValue_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Preferred stock- $0.0001 par value">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98D_eus-gaap--PreferredStockValue_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Preferred stock- $0.0001 par value">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--PreferredStockValue_c20210114_pp0p0" style="text-align: right" title="Preferred stock- $0.0001 par value">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt">Common stock - $<span class="xdx_phnt_RGlzY2xvc3VyZSAtIFNjaGVkdWxlIG9mIFJlc3RhdGVtZW50IG9mIEJhbGFuY2UgU2hlZXQgKERldGFpbHMpIChQYXJlbnRoZXRpY2FsKQA_" id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_pid_c20210114_zPAUQXQrv5Mh" title="Common stock, par value">0.0001 par value</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_985_eus-gaap--CommonStockValue_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Common stock - $0.0001 par value">398</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--CommonStockValue_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Common stock - $0.0001 par value">81</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_987_eus-gaap--CommonStockValue_c20210114_pp0p0" style="text-align: right" title="Common stock - $0.0001 par value">479</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-left: 10pt">Additional paid-in-capital</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_989_eus-gaap--AdditionalPaidInCapital_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="text-align: right" title="Additional paid-in-capital">5,003,838</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98C_eus-gaap--AdditionalPaidInCapital_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="text-align: right" title="Additional paid-in-capital">355,669</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--AdditionalPaidInCapital_c20210114_pp0p0" style="text-align: right" title="Additional paid-in-capital">5,359,507</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt; padding-left: 10pt">Accumulated deficit</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_986_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated deficit">(4,232</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98A_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated deficit">(355,750</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_980_eus-gaap--RetainedEarningsAccumulatedDeficit_c20210114_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Accumulated deficit">(359,982</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total stockholders’ equity</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98B_eus-gaap--StockholdersEquity_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total stockholders' equity">5,000,004</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_988_eus-gaap--StockholdersEquity_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total stockholders' equity">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_987_eus-gaap--StockholdersEquity_c20210114_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Total stockholders' equity">5,000,004</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Total liabilities and stockholders’ equity</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_989_eus-gaap--LiabilitiesAndStockholdersEquity_iI_pp0p0_c20210114__srt--RestatementAxis__srt--ScenarioPreviouslyReportedMember_zKMRLNTWoI64" style="border-bottom: Black 2.5pt double; text-align: right" title="Total liabilities and stockholders' equity">117,645,054</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98B_eus-gaap--LiabilitiesAndStockholdersEquity_iI_pp0p0_c20210114__srt--RestatementAxis__srt--RestatementAdjustmentMember_zn1QSTlxRoO4" style="border-bottom: Black 2.5pt double; text-align: right" title="Total liabilities and stockholders' equity">—</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98C_eus-gaap--LiabilitiesAndStockholdersEquity_iI_pp0p0_c20210114_zpiQ9JOo06x1" style="border-bottom: Black 2.5pt double; text-align: right" title="Total liabilities and stockholders' equity">117,645,054</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

117645054

117645045

267540

7025183

4488040

7025183

11513223

0.0001

108157010

-7025183

101131827

0.0001

398

479

5003838

355669

5359507

-4232

-355750

-359982

5000004

117645054

Note 3 — Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the SEC on April 2, 2021, which contains the audited financial statements and notes thereto. The interim results for the three months and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods. Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020. Marketable Securities Held in Trust Account At June 30, 2021, substantially all of the assets held in the Trust Account were held in money market funds which invest in U.S. Treasury securities. Warrant Liabilities The Company evaluated the Public Warrants and Private Placement Warrants (collectively, “Warrants”, which are discussed in Note 2, Note 4, Note 5 and Note 9) in accordance with ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity”, and concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities on the Condensed Balance Sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in the Condensed Statement of Operations in the period of change. <p id="xdx_848_ecustom--OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock_zI1Wn50Wphba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock were charged to stockholders’ equity upon the completion of the Initial Public Offering. Transaction costs for the six month ended June 30, 2021 amounted to $6,108,360, of which $359,874 were allocated to expense associated with the warrant liability. Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets. Income Taxes The Company accounts for income taxes under ASC 740, Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The deferred tax assets were deemed to be de minimis as of June 30, 2021 and December 31, 2020. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income tax examinations by major taxing authorities since inception. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The provision for income taxes was deemed to be de minimis for the period ended June 30, 2021. Net Income Per Common Share Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at June 30, 2021, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings, less the Company’s portion available to pay taxes. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase <span id="xdx_901_eus-gaap--StockIssued1_pp0p0_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zUbhLb35DbA1" title="Stock Issued">5,958,600 shares of common stock in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events. As a result, diluted net loss per common share is the same as basic net loss per common share for the period presented. Net Income per Common Share The Company’s net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows: Schedule of Reconciliation of Net Income Per Common Share <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20210401__20210630_zIlQiRj4X4tj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30, 2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20210101__20210630_zQomjgJJt527" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Common Stock Subject to Possible Redemption</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Numerator: Earnings allocable to common stock subject to possible redemption</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InterestExpense_msNIATSz3VR_maTEATRzO4E_zqGHYfc0896e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 62%; text-align: left">Interest earned on marketable securities held in Trust Account</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 16%; text-align: right">2,896</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 16%; text-align: right">5,315</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--InterestAllocableToNonredeemableCommonStock_iN_di_msNIATSz3VR_msTEATRzO4E_zXtzQHHSpRai" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less: Interest allocable to non-redeemable common stock</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(915</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(1,680</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_iT_mtTEATRzO4E_zSyVpHJ0K8Z1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left">Net income allocable to shares subject to possible redemption</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">1,981</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">3,635</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Denominator: Weighted Average Redeemable Class A Ordinary Shares</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--WeightedAverageRedeemableClassAOrdinarySharesWeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_zUi364Frcmq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Basic and diluted weighted average shares outstanding</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">10,333,213</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">10,363,269</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--WeightedAverageRedeemableClassAOrdinarySharesEarningsPerShareBasicAndDiluted_pid_zsfN9KYPwwjh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income per share</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.00</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.00</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Non-Redeemable Common Stock</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Numerator: Net Income (Loss) Minus Net Earnings</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_maNNILzyDI_zXU2khVEZ1ki" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Net Income (Loss)</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">(2,202,161</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">771,059</td> <td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_iN_di_msNNILzyDI_zZOYwHrn0Pmi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less: Income attributable to common stock subject to possible redemption</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(1,981</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(3,635</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_ecustom--NonredeemableNetIncomeLoss_iT_pp0p0_mtNNILzyDI_zLcAGxQFfiYe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Non-Redeemable net income (loss)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">(2,204,142</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">767,424</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_zCgi6jvsGKe6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted average non-redeemable shares outstanding, basic and diluted</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">4,443,103</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">4,162,957</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDiluted_pid_zFfDklATh0Q7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income (loss) per share</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">(0.50</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.18</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Fair Value of Financial Instruments The Company follows the guidance in ASC 820, “Fair Value Measurement,” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.65in; text-align: justify">Level 1 —</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify">Level 2 —</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify">Level 3 —</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</td></tr> </table> See Note 9 for additional information on assets and liabilities measured at fair value. Recently Adopted Accounting Standards In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company early adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows. Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Basis of Presentation The accompanying unaudited condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and in accordance with the instructions to Form 10-Q and Article 10 of Regulation S-X of the SEC. Certain information or footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted, pursuant to the rules and regulations of the SEC for interim financial reporting. Accordingly, they do not include all the information and footnotes necessary for a complete presentation of financial position, results of operations, or cash flows. In the opinion of management, the accompanying unaudited condensed financial statements include all adjustments, consisting of a normal recurring nature, which are necessary for a fair presentation of the financial position, operating results and cash flows for the periods presented The accompanying unaudited condensed financial statements should be read in conjunction with the Company’s Annual Report on Form 10-K for the year ended December 31, 2020 as filed with the SEC on April 2, 2021, which contains the audited financial statements and notes thereto. The interim results for the three months and six months ended June 30, 2021 are not necessarily indicative of the results to be expected for the year ending December 31, 2021 or for any future interim periods.

Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of June 30, 2021 and December 31, 2020.

Marketable Securities Held in Trust Account At June 30, 2021, substantially all of the assets held in the Trust Account were held in money market funds which invest in U.S. Treasury securities.

Warrant Liabilities The Company evaluated the Public Warrants and Private Placement Warrants (collectively, “Warrants”, which are discussed in Note 2, Note 4, Note 5 and Note 9) in accordance with ASC 815-40, “Derivatives and Hedging — Contracts in Entity’s Own Equity”, and concluded that a provision in the Warrant Agreement related to certain tender or exchange offers precludes the Warrants from being accounted for as components of equity. As the Warrants meet the definition of a derivative as contemplated in ASC 815, the Warrants are recorded as derivative liabilities on the Condensed Balance Sheet and measured at fair value at inception (on the date of the IPO) and at each reporting date in accordance with ASC 820, “Fair Value Measurement”, with changes in fair value recognized in the Condensed Statement of Operations in the period of change. <p id="xdx_848_ecustom--OfferingCostsAssociatedWithInitialPublicOfferingPolicyTextBlock_zI1Wn50Wphba" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; background-color: white">Offering Costs Associated with the Initial Public Offering The Company complies with the requirements of the ASC 340-10-S99-1. Offering costs consisted of legal, accounting, underwriting fees and other costs incurred through the Initial Public Offering that were directly related to the Initial Public Offering. Offering costs are allocated to the separable financial instruments issued in the Initial Public Offering based on a relative fair value basis, compared to total proceeds received. Offering costs associated with warrant liabilities are expensed as incurred, presented as non-operating expenses in the statement of operations. Offering costs associated with the Class A common stock were charged to stockholders’ equity upon the completion of the Initial Public Offering. Transaction costs for the six month ended June 30, 2021 amounted to $6,108,360, of which $359,874 were allocated to expense associated with the warrant liability.

6108360

359874 Common Stock Subject to Possible Redemption The Company accounts for its common stock subject to possible redemption in accordance with the guidance in Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” Common stock subject to mandatory redemption is classified as a liability instrument and is measured at fair value. Conditionally redeemable common stock (including common stock that features redemption rights that is either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company’s control) is classified as temporary equity. At all other times, common stock is classified as stockholders’ equity. The Company’s common stock features certain redemption rights that are considered to be outside of the Company’s control and subject to occurrence of uncertain future events. Accordingly, common stock subject to possible redemption is presented at redemption value as temporary equity, outside of the stockholders’ equity section of the Company’s condensed balance sheets.

Income Taxes The Company accounts for income taxes under ASC 740, Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The deferred tax assets were deemed to be de minimis as of June 30, 2021 and December 31, 2020. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of June 30, 2021 and December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income tax examinations by major taxing authorities since inception. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The provision for income taxes was deemed to be de minimis for the period ended June 30, 2021.

Net Income Per Common Share Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period. The Company applies the two-class method in calculating earnings per share. Shares of common stock subject to possible redemption at June 30, 2021, which are not currently redeemable and are not redeemable at fair value, have been excluded from the calculation of basic net loss per common share since such shares, if redeemed, only participate in their pro rata share of the Trust Account earnings, less the Company’s portion available to pay taxes. The Company has not considered the effect of warrants sold in the Initial Public Offering and the private placement to purchase <span id="xdx_901_eus-gaap--StockIssued1_pp0p0_c20210101__20210630__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--PrivatePlacementMember_zUbhLb35DbA1" title="Stock Issued">5,958,600 shares of common stock in the calculation of diluted loss per share, since the exercise of the warrants are contingent upon the occurrence of future events. As a result, diluted net loss per common share is the same as basic net loss per common share for the period presented. Net Income per Common Share The Company’s net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows: Schedule of Reconciliation of Net Income Per Common Share <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20210401__20210630_zIlQiRj4X4tj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30, 2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20210101__20210630_zQomjgJJt527" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Common Stock Subject to Possible Redemption</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Numerator: Earnings allocable to common stock subject to possible redemption</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InterestExpense_msNIATSz3VR_maTEATRzO4E_zqGHYfc0896e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 62%; text-align: left">Interest earned on marketable securities held in Trust Account</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 16%; text-align: right">2,896</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 16%; text-align: right">5,315</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--InterestAllocableToNonredeemableCommonStock_iN_di_msNIATSz3VR_msTEATRzO4E_zXtzQHHSpRai" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less: Interest allocable to non-redeemable common stock</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(915</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(1,680</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_iT_mtTEATRzO4E_zSyVpHJ0K8Z1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left">Net income allocable to shares subject to possible redemption</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">1,981</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">3,635</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Denominator: Weighted Average Redeemable Class A Ordinary Shares</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--WeightedAverageRedeemableClassAOrdinarySharesWeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_zUi364Frcmq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Basic and diluted weighted average shares outstanding</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">10,333,213</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">10,363,269</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--WeightedAverageRedeemableClassAOrdinarySharesEarningsPerShareBasicAndDiluted_pid_zsfN9KYPwwjh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income per share</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.00</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.00</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Non-Redeemable Common Stock</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Numerator: Net Income (Loss) Minus Net Earnings</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_maNNILzyDI_zXU2khVEZ1ki" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Net Income (Loss)</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">(2,202,161</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">771,059</td> <td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_iN_di_msNNILzyDI_zZOYwHrn0Pmi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less: Income attributable to common stock subject to possible redemption</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(1,981</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(3,635</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_ecustom--NonredeemableNetIncomeLoss_iT_pp0p0_mtNNILzyDI_zLcAGxQFfiYe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Non-Redeemable net income (loss)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">(2,204,142</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">767,424</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_zCgi6jvsGKe6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted average non-redeemable shares outstanding, basic and diluted</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">4,443,103</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">4,162,957</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDiluted_pid_zFfDklATh0Q7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income (loss) per share</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">(0.50</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.18</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

5958600

The Company’s net income is adjusted for the portion of income that is attributable to common stock subject to possible redemption, as these shares only participate in the earnings of the Trust Account and not the income or losses of the Company. Accordingly, basic and diluted loss per common share is calculated as follows: Schedule of Reconciliation of Net Income Per Common Share <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20210401__20210630_zIlQiRj4X4tj" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Three Months Ended June 30, 2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20210101__20210630_zQomjgJJt527" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Six Months Ended June 30, 2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Common Stock Subject to Possible Redemption</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Numerator: Earnings allocable to common stock subject to possible redemption</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--InterestExpense_msNIATSz3VR_maTEATRzO4E_zqGHYfc0896e" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; width: 62%; text-align: left">Interest earned on marketable securities held in Trust Account</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 16%; text-align: right">2,896</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 16%; text-align: right">5,315</td> <td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--InterestAllocableToNonredeemableCommonStock_iN_di_msNIATSz3VR_msTEATRzO4E_zXtzQHHSpRai" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less: Interest allocable to non-redeemable common stock</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(915</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(1,680</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_402_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_iT_mtTEATRzO4E_zSyVpHJ0K8Z1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left">Net income allocable to shares subject to possible redemption</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">1,981</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">3,635</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Denominator: Weighted Average Redeemable Class A Ordinary Shares</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_40A_ecustom--WeightedAverageRedeemableClassAOrdinarySharesWeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_zUi364Frcmq3" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Basic and diluted weighted average shares outstanding</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">10,333,213</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">10,363,269</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--WeightedAverageRedeemableClassAOrdinarySharesEarningsPerShareBasicAndDiluted_pid_zsfN9KYPwwjh" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income per share</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.00</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.00</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-style: italic; text-align: left">Non-Redeemable Common Stock</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Numerator: Net Income (Loss) Minus Net Earnings</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--NetIncomeLoss_maNNILzyDI_zXU2khVEZ1ki" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Net Income (Loss)</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">(2,202,161</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left">$</td> <td style="text-align: right">771,059</td> <td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--TemporaryEquityAccretionToRedemptionValueAdjustment_iN_di_msNNILzyDI_zZOYwHrn0Pmi" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Less: Income attributable to common stock subject to possible redemption</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(1,981</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(3,635</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_401_ecustom--NonredeemableNetIncomeLoss_iT_pp0p0_mtNNILzyDI_zLcAGxQFfiYe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 20pt; text-align: left; padding-bottom: 2.5pt">Non-Redeemable net income (loss)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">(2,204,142</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">767,424</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--WeightedAverageNumberOfShareOutstandingBasicAndDiluted_pid_zCgi6jvsGKe6" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Weighted average non-redeemable shares outstanding, basic and diluted</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">4,443,103</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left"> </td> <td style="border-bottom: Black 2.5pt double; text-align: right">4,162,957</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--EarningsPerShareBasicAndDiluted_pid_zFfDklATh0Q7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Basic and diluted net income (loss) per share</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">(0.50</td> <td style="padding-bottom: 2.5pt; text-align: left">)</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td style="border-bottom: Black 2.5pt double; text-align: right">0.18</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

2896

5315

915 1680

1981

3635

10333213 10363269 0.00 0.00

-2202161

771059

1981

3635

-2204142 767424

4443103

4162957

-0.50

0.18

Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

250000

Fair Value of Financial Instruments The Company follows the guidance in ASC 820, “Fair Value Measurement,” for its financial assets and liabilities that are re-measured and reported at fair value at each reporting period, and non-financial assets and liabilities that are re-measured and reported at fair value at least annually. The fair value of the Company’s financial assets and liabilities reflects management’s estimate of amounts that the Company would have received in connection with the sale of the assets or paid in connection with the transfer of the liabilities in an orderly transaction between market participants at the measurement date. In connection with measuring the fair value of its assets and liabilities, the Company seeks to maximize the use of observable inputs (market data obtained from independent sources) and to minimize the use of unobservable inputs (internal assumptions about how market participants would price assets and liabilities). The following fair value hierarchy is used to classify assets and liabilities based on the observable inputs and unobservable inputs used in order to value the assets and liabilities: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; width: 0.65in; text-align: justify">Level 1 —</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access. Valuation adjustments and block discounts are not being applied. Since valuations are based on quoted prices that are readily and regularly available in an active market, valuation of these securities does not entail a significant degree of judgment.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify">Level 2 —</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Valuations based on (i) quoted prices in active markets for similar assets and liabilities, (ii) quoted prices in markets that are not active for identical or similar assets, (iii) inputs other than quoted prices for the assets or liabilities, or (iv) inputs that are derived principally from or corroborated by market through correlation or other means.</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: justify">Level 3 —</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</td></tr> </table> See Note 9 for additional information on assets and liabilities measured at fair value.

Recently Adopted Accounting Standards In August 2020, the FASB issued ASU 2020-06, Debt-Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging-Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity (“ASU 2020-06”), which simplifies accounting for convertible instruments by removing major separation models required under current GAAP. The ASU also removes certain settlement conditions that are required for equity-linked contracts to qualify for scope exception, and it simplifies the diluted earnings per share calculation in certain areas. The Company early adopted ASU 2020-06 on January 1, 2021. Adoption of the ASU did not impact the Company’s financial position, results of operations or cash flows.

Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Note 4 — Initial Public Offering Public Units On January 14, 2021, the Company sold <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zkVIs9f9H514" title="Units issued during the period, shares">11,500,000 Units, at a purchase price of $10.00 per Unit, which includes the full exercise by the underwriters of the over-allotment option to purchase an additional <span id="xdx_901_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zZpWhYmjLRug" title="Units issued during the period, shares">1,500,000 Units, at a purchase price of $10.00 per Unit. Each Unit consists of one share of common stock, and one-half warrant to purchase one share of common stock (the “Public Warrants”). Public Warrants Each whole warrant entitles the holder to purchase one share of the Company’s common stock at a price of $11.50 per share, subject to adjustment as discussed herein. The warrants will become exercisable on the later of 12 months from the closing of this offering or 30 days after the completion of its initial business combination, and will expire five years after the completion of the Company’s initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s sponsor or its affiliates, without taking into account any founder shares held by the Company’s sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying the warrants is then effective and a prospectus is current. No warrant will be exercisable and the Company will not be obligated to issue shares of common stock upon exercise of a warrant unless common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of common stock underlying such unit. Once the warrants become exercisable, the Company may call the warrants for redemption: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">in whole and not in part;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">at a price of $0.01 per warrant;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">if, and only if, the reported last sale price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders.</td></tr> </table> If the Company calls the warrants for redemption as described above, the management will have the option to require any holder that wishes to exercise its warrant to do so on a “cashless basis.” If the management exercises this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the excess of the “fair market value” (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants.

11500000

10.00

1500000

10.00

11.50

In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s sponsor or its affiliates, without taking into account any founder shares held by the Company’s sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

0.01

the reported last sale price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company sends the notice of redemption to the warrant holders. Note 5 — Private Placement Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of <span id="xdx_906_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_uShares_c20210101__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_zexFcExcvvAf" title="Sale of units">417,200 Placement Units, at a price of $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_zCAmUyfhpHs9" title="Unit issued price">10.00 per Placement Unit, for an aggregate purchase price of $<span id="xdx_90C_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pp0p0_c20210101__20210630__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_zPr9x0jCTLS4" title="Proceeds from sale of units">4,172,000, in a private placement. A portion of the proceeds from the private placement was added to the proceeds from the IPO held in the Trust. Each Placement Unit was identical to the Units sold in the IPO, except for the placement warrants (“Placement Warrants”). The Placement Warrants and the common stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or saleable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. If the Company does not complete its initial business combination within 15 months (or up to 21 months) from the closing of this IPO, the proceeds from the sale of the Placement Units held in the trust account will be used to fund the redemption of its public shares (subject to the requirements of applicable law) and the Placement Warrants will expire.

417200

10.00

4172000

Note 6 — Related Party Transactions Founder Shares On November 12, 2020, the Company issued <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20201110__20201113__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zZj7mE0NZYMf" title="Stock issued during the period, shares">2,156,250 shares of common stock to the Sponsor for $<span id="xdx_908_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20201110__20201113__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_z0RnpYyCGzM9" title="Stock issued during the period">25,000 in cash, or approximately $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20201113__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zrqj1LeHULpb" title="Shares issued price per share">0.012 per share, in connection with formation. On December 7, 2020, the Sponsor forfeited <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pid_uShares_c20201206__20201207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zr9HeortWKT3" title="Shares forfeited during the period">161,719 founder shares to the Company and Ladenburg Thalmann & Co. Inc., the representative of the underwriters, and certain of its employees (“Ladenburg”) purchased from the Company an aggregate of <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20201206__20201207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zjTf2Ardu8N5" title="Stock issued during the period, shares">161,719 representative shares at an average purchase price of approximately $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20201207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zCtzJDszBiih" title="Shares issued price per share">0.012 per share, for an aggregate purchase price of $<span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20201206__20201207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zBDAjmpb1cJl" title="Stock issued during the period">1,875. On January 3, 2021, the Company effected a stock dividend of 1/3 of a share of common stock for every share of common stock outstanding, resulting in an aggregate of 2,875,000 founder shares outstanding (including up to <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pid_uShares_c20210102__20210103__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_z4yqnHvkOJDh" title="Shares forfeited during the period">375,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part). As a result of the underwriters’ election to fully exercise their over-allotment option on January 14, 2021, the <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_uShares_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zMt8umWwP15c" title="Shares exercised during the period">375,000 shares are no longer subject to forfeiture. As discussed further below, on January 4, 2021, the Sponsor forfeited <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pid_uShares_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_ziXIwDHEG5h4">28,750 founder shares to the Company and Ladenburg and certain of its employees purchased from the Company an aggregate of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zcevqSmd6Sza">28,750 representative shares at an average purchase price of approximately $0.008 per share, for an aggregate purchase price of $<span id="xdx_905_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_z987D6LOncEd">230. As a result, the Sponsor currently owns <span id="xdx_902_ecustom--SharesOwned_pid_uShares_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zVWFvbcWYeS9">2,630,625 shares. <span id="xdx_90B_ecustom--AgreementDescription_c20210101__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zpDoLPk2CDf2" title="Agreement description">The Sponsor has agreed not to transfer, assign or sell 50% of its founder shares until the earlier to occur of (A) six months after the completion of the Company’s initial business combination or (B) the date the last sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial business combination, and the remaining 50% of the founder shares until six months after the completion of the Company’s initial business combination, or earlier, if, in either case, subsequent to the Company’s initial business combination, the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property. Representative Shares On December 7, 2020, the Sponsor forfeited <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pid_uShares_c20211206__20211207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zPifSyoHxyF3">161,719 founder shares to the Company and Ladenburg and certain of its employees purchased from the Company an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20211206__20211207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zBbMKQJEeDJ5">161,719 representative shares at an average purchase price of approximately $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20211207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zhWzdRhQdSY4">0.012 per share, for an aggregate purchase price of $<span id="xdx_901_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20211206__20211207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pp0p0">1,875. On January 4, 2021, the Sponsor forfeited <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pid_uShares_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_z5nu9NxORuT7">28,750 founder shares to the Company and Ladenburg and certain of its employees purchased from the Company an aggregate of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_uShares_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zK2eKzVhNwoa">28,750 representative shares at an average purchase price of approximately $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zFYVzDWpN0gj">0.008 per share, for an aggregate purchase price of $<span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pp0p0">230. Following the 1/3 common stock dividend effected January 3, 2021 (as described herein), Ladenburg and certain of its employees now hold an aggregate of <span id="xdx_909_ecustom--SharesOwned_pid_uShares_c20210102__20210103__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zW8M7dLiPRTh">244,375 representative shares (of which up to <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pid_uShares_c20210102__20210103__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zhGGxD8OeGk5">31,875 were subject to forfeiture). As a result of the underwriters’ election to fully exercise of their over-allotment option, the <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pid_uShares_c20210102__20210103__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zD6hDkO8plSj">31,875 shares are no longer subject to forfeiture. Ladenburg and certain of its employees have entered into a subscription agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their representative shares, as applicable, and public shares in connection with the completion of our initial business combination, (ii) waive their redemption rights with respect to their representative shares, as applicable, (iii) waive their rights to liquidating distributions from the trust account with respect to their representative shares if the Company fails to complete the initial business combination within the Combination Period. Promissory Note — Related Party On November 19, 2020, Company issued an unsecured promissory note to the Sponsor for an aggregate of up to $250,000 to cover expenses related to the IPO. <span id="xdx_90B_eus-gaap--DebtInstrumentMaturityDateDescription_c20201118__20201119__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zJYJKLIXWfFh" title="Debt instrument maturity date">This loan was non-interest bearing and payable on the earlier of March 31, 2021 or the completion of the IPO. As of December 31, 2020, the Company had drawn down $150,000 under the promissory note. On January 14, 2021, the Company paid the $150,000 balance on the note from the proceeds of the IPO. Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into units at a price of $10.00 per unit at the option of the lender, upon consummation of the Company’s Initial Business Combination. The units would be identical to the Placement Units. Through June 30, 2021, no Working Capital Loans had been made. Administrative Service Fee The Company has agreed to pay an affiliate of the Company’s Sponsor a monthly fee of an aggregate of $10,000 for office space, utilities and secretarial and administrative support. Upon completion of the Company’s Business Combination or its liquidation, the Company will cease paying these monthly fees. For the three and six months ended June 30, 2021, the Company has recorded $30,000 and $60,000 in service fee expense, respectively, within operating costs in the accompanying condensed financial statements of operations.

2156250

25000

0.012

161719

0.012

1875

2875000

375000

28750

230

2630625 The Sponsor has agreed not to transfer, assign or sell 50% of its founder shares until the earlier to occur of (A) six months after the completion of the Company’s initial business combination or (B) the date the last sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial business combination, and the remaining 50% of the founder shares until six months after the completion of the Company’s initial business combination, or earlier, if, in either case, subsequent to the Company’s initial business combination, the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property.

161719

0.012

1875

28750

0.008

230

244375

31875

250000

This loan was non-interest bearing and payable on the earlier of March 31, 2021 or the completion of the IPO.

150000

Up to $1,500,000 of such Working Capital Loans may be convertible into units at a price of $10.00 per unit at the option of the lender, upon consummation of the Company’s Initial Business Combination.

10000

30000 60000

Note 7 — Commitments and Contingencies Underwriting Agreement The underwriter had a 45-day option from the date of the IPO to purchase up to an aggregate of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_pdd" title="Units issued during the period, shares"><span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_pdd" title="Units issued during the period, shares">1,500,000 additional Units at the public offering price less the underwriting commissions to cover over-allotments, if any. On January 14, 2021, the underwriter fully exercised its over-allotment option. Upon consummation of the IPO on January 14, 2021, the underwriters were paid a cash underwriting fee of <span id="xdx_90A_ecustom--CashUnderwritingFeePercentage_pid_dp_uPercent_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_z5ctSEEWvC78" title="Cash underwriting fee, percentage">1.33% of the gross proceeds of the IPO, or $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_pp0p0" title="Gross proceeds from IPO">1,529,500 in the aggregate. The underwriters are entitled to a deferred underwriting fee of <span id="xdx_90D_ecustom--DeferredUnderwritingFeePercentage_pid_dp_uPercent_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zns8LoiEUdw5">3.67% of the gross proceeds of the IPO, or $4,220,500 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Registration Rights The holders of the founder shares, representative shares, placement units, and units that may be issued upon conversion of working capital loans will have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement to be signed prior to or on the effective date of this offering. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

1500000

0.0133

1529500

0.0367 4220500

Note 8 — Stockholders’ Equity Preferred Stock — The Company is authorized to issue a total of 1,000,000 preferred shares at par value of $0.0001 each. At June 30, 2021 and December 31, 2020, there were no shares of preferred stock issued or outstanding. Common Stock — The Company is authorized to issue a total of 50,000,000 share of common stock at par value of $0.0001 each. At June 30, 2021 and December 31, 2020, there were 4,674,626 and 2,875,000 shares issued and outstanding, excluding 10,117,574 and no shares subject to possible redemption, respectively. The Company’s initial stockholder has agreed not to transfer, assign or sell 50% of its founder shares until the earlier to occur of (A) six months after the completion of the Company’s initial business combination or (B) the date the last sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial business combination, and not to transfer, assign or sell the remaining 50% of the founder shares until six months after the completion of the Company’s initial business combination, or earlier, if, in either case, subsequent to the Company’s initial business combination, the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Company’s initial stockholders with respect to any founder shares.

1000000

0.0001

50000000

0.0001

4674626

2875000

10117574

The Company’s initial stockholder has agreed not to transfer, assign or sell 50% of its founder shares until the earlier to occur of (A) six months after the completion of the Company’s initial business combination or (B) the date the last sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial business combination, and not to transfer, assign or sell the remaining 50% of the founder shares until six months after the completion of the Company’s initial business combination, or earlier, if, in either case, subsequent to the Company’s initial business combination, the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Company’s initial stockholders with respect to any founder shares.

12.50

Note 9 — Fair Value Measurements The following table presents information about the Company’s assets and liabilities that are measured at fair value on a recurring basis at June 30, 2021, and indicates the fair value hierarchy of the valuation inputs the Company utilized to determine such fair value: Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Quoted Prices In Active Markets</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant Other Observable Inputs</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant Other Unobservable Inputs</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 2)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 3)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt">U.S. Money Market held in Trust Account</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_988_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20210630_zL9PG5BUv4uk" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="U.S. Money Market held in Trust Account">116,155,315</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_980_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zivOmK0mEB4k" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="U.S. Money Market held in Trust Account">116,155,315</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_98D_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zg4qgBSJKqp6" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="U.S. Money Market held in Trust Account">—</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_98F_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgL1Xl71R9j1" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="U.S. Money Market held in Trust Account">—</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Liabilities:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Public Warrants Liability</td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98B_ecustom--PublicWarrantsLiability_c20210630_pp0p0" style="text-align: right" title="Public Warrants Liability">5,289,425</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_984_ecustom--PublicWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="text-align: right" title="Public Warrants Liability">5,289,425</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_985_ecustom--PublicWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="text-align: right" title="Public Warrants Liability">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_982_ecustom--PublicWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="text-align: right" title="Public Warrants Liability">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Private Placement Warrants Liability</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_988_ecustom--PrivatePlacementWarrantsLiability_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Private Placement Warrants Liability">241,681</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98C_ecustom--PrivatePlacementWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Private Placement Warrants Liability">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_983_ecustom--PrivatePlacementWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Private Placement Warrants Liability">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_982_ecustom--PrivatePlacementWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Private Placement Warrants Liability">241,681</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Fair value of liabilities</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_988_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">5,531,106</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_980_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">5,289,425</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_983_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">—</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_982_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">241,681</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The Warrants are accounted for as liabilities in accordance with ASC 815-40 and are presented within warrant liabilities on the Condensed Balance Sheet. The warrant liabilities are measured at fair value at inception and on a recurring basis, with changes in fair value presented within change in fair value of warrant liabilities in the Condensed Statement of Operations. The Company established the initial fair value of the Public Warrants and Private Warrants on January 14, 2021, the date of the Company’s Initial Public Offering, using a Monte Carlo simulation model. On June 30, 2021, the Company established the fair value of the Private Warrants using a Monto Carlo simulation model, and the fair value of the Public Warrants by reference to the quoted market price. The Public Warrants have traded on Nasdaq stock market since January 14, 2021 under the trading symbol BCYPW. The Public and Private Warrants were classified as Level 3 at June 30, 2021 and the Private Warrants were classified as Level 3 at June 30, 2021 due to the use of unobservable inputs. As of June 30, 2021, the Public Warrants were transferred to Level 1 due to the use of the quoted market price. The following table presents the changes in the fair value of the Level 3 liabilities: Schedule of Change in Fair Value Liabilities <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Private Placement Warrants</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Public Warrants</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Warrant Liabilities</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Fair Value as of December 31, 2020</td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PrivatePlacementWarrantsMember_zlve3gSuu1m8" style="text-align: right" title="Fair Value Beginning">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PublicWarrantsMember_z3DesM7UdzEl" style="text-align: right" title="Fair Value Beginning">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsLiabilitiesMember_zuBWmTd2TF1i" style="text-align: right" title="Fair Value Beginning">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 47%">Initial measurement on January 14, 2021</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PrivatePlacementWarrantsMember_pp0p0" style="width: 16%; text-align: right" title="Initial Measurement">249,963</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PublicWarrantsMember_pp0p0" style="width: 14%; text-align: right" title="Initial Measurement">6,775,220</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsLiabilitiesMember_pp0p0" style="width: 14%; text-align: right" title="Initial Measurement">7,025,183</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in valuation</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PrivatePlacementWarrantsMember_pp0p0" style="text-align: right" title="Change in valuation">(8,282</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PublicWarrantsMember_pp0p0" style="text-align: right" title="Change in valuation">(1,485,795</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsLiabilitiesMember_pp0p0" style="text-align: right" title="Change in valuation">(1,494,077</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Transferred to Level 1</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_984_ecustom--TransferredToLevel1_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PrivatePlacementWarrantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transferred to Level 1">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98D_ecustom--TransferredToLevel1_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PublicWarrantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transferred to Level 1">(5,289,425</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_988_ecustom--TransferredToLevel1_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsLiabilitiesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transferred to Level 1">(5,289,425</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, June 30, 2021</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PrivatePlacementWarrantsMember_zJ8CDwLSwVA3" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">241,681</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PublicWarrantsMember_zkLpbBwnQpsb" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">—</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98C_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsLiabilitiesMember_zl5vHTrVaKab" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">241,681</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> The key inputs into the Monte Carlo simulation as of January 14, 2021 and June 30, 2021 were as follows: Schedule of Key Inputs into Monte Carlo Simulation <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Initial Measurement)</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Inputs</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">January 14, 2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">Risk-free interest rate</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPercent_c20210113__20210114_zyXpxvc4IFoj" style="width: 18%; text-align: right" title="Risk-free interest rate">0.60</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPercent_c20210101__20210630_zuZgn2KW7fyf" style="width: 18%; text-align: right" title="Risk-free interest rate">0.90</td> <td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected term remaining (years)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5.67</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5.19</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">24.2</td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">19.8</td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Stock price</td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20210114_zCXVmjVSChDc" style="text-align: right" title="Stock price">9.41</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20210630_zC28cdJprtw9" style="text-align: right" title="Stock price">9.96</td> <td style="text-align: left"> </td></tr> </table>

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Quoted Prices In Active Markets</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant Other Observable Inputs</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Significant Other Unobservable Inputs</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 1)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 2)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">(Level 3)</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Assets:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 48%; text-align: left; padding-bottom: 2.5pt">U.S. Money Market held in Trust Account</td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_988_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20210630_zL9PG5BUv4uk" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="U.S. Money Market held in Trust Account">116,155,315</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_980_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zivOmK0mEB4k" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="U.S. Money Market held in Trust Account">116,155,315</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_98D_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zg4qgBSJKqp6" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="U.S. Money Market held in Trust Account">—</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td> <td style="width: 1%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; width: 1%; text-align: left">$</td> <td id="xdx_98F_eus-gaap--AssetsHeldInTrustNoncurrent_iI_pp0p0_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zgL1Xl71R9j1" style="border-bottom: Black 2.5pt double; width: 10%; text-align: right" title="U.S. Money Market held in Trust Account">—</td> <td style="width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Liabilities:</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Public Warrants Liability</td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98B_ecustom--PublicWarrantsLiability_c20210630_pp0p0" style="text-align: right" title="Public Warrants Liability">5,289,425</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_984_ecustom--PublicWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="text-align: right" title="Public Warrants Liability">5,289,425</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_985_ecustom--PublicWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="text-align: right" title="Public Warrants Liability">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_982_ecustom--PublicWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="text-align: right" title="Public Warrants Liability">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Private Placement Warrants Liability</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_988_ecustom--PrivatePlacementWarrantsLiability_c20210630_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Private Placement Warrants Liability">241,681</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98C_ecustom--PrivatePlacementWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Private Placement Warrants Liability">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_983_ecustom--PrivatePlacementWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Private Placement Warrants Liability">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_982_ecustom--PrivatePlacementWarrantsLiability_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Private Placement Warrants Liability">241,681</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Fair value of liabilities</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_988_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210630_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">5,531,106</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_980_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">5,289,425</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_983_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">—</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_982_eus-gaap--DerivativeLiabilitiesNoncurrent_c20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_pp0p0" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">241,681</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

116155315

5289425 5289425 241681 241681

5531106

5289425

241681

The following table presents the changes in the fair value of the Level 3 liabilities: Schedule of Change in Fair Value Liabilities <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Private Placement Warrants</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Public Warrants</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Warrant Liabilities</td> <td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Fair Value as of December 31, 2020</td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PrivatePlacementWarrantsMember_zlve3gSuu1m8" style="text-align: right" title="Fair Value Beginning">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PublicWarrantsMember_z3DesM7UdzEl" style="text-align: right" title="Fair Value Beginning">—</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsLiabilitiesMember_zuBWmTd2TF1i" style="text-align: right" title="Fair Value Beginning">—</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 47%">Initial measurement on January 14, 2021</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PrivatePlacementWarrantsMember_pp0p0" style="width: 16%; text-align: right" title="Initial Measurement">249,963</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PublicWarrantsMember_pp0p0" style="width: 14%; text-align: right" title="Initial Measurement">6,775,220</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsLiabilitiesMember_pp0p0" style="width: 14%; text-align: right" title="Initial Measurement">7,025,183</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Change in valuation</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PrivatePlacementWarrantsMember_pp0p0" style="text-align: right" title="Change in valuation">(8,282</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PublicWarrantsMember_pp0p0" style="text-align: right" title="Change in valuation">(1,485,795</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsLiabilitiesMember_pp0p0" style="text-align: right" title="Change in valuation">(1,494,077</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Transferred to Level 1</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_984_ecustom--TransferredToLevel1_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PrivatePlacementWarrantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transferred to Level 1">—</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_98D_ecustom--TransferredToLevel1_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PublicWarrantsMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transferred to Level 1">(5,289,425</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td id="xdx_988_ecustom--TransferredToLevel1_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsLiabilitiesMember_pp0p0" style="border-bottom: Black 1.5pt solid; text-align: right" title="Transferred to Level 1">(5,289,425</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 2.5pt">Balance, June 30, 2021</td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_984_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PrivatePlacementWarrantsMember_zJ8CDwLSwVA3" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">241,681</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_983_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--PublicWarrantsMember_zkLpbBwnQpsb" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">—</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td> <td id="xdx_98C_eus-gaap--DerivativeFairValueOfDerivativeNet_iE_pp0p0_c20210101__20210630__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--DerivativeInstrumentRiskAxis__custom--WarrantsLiabilitiesMember_zl5vHTrVaKab" style="border-bottom: Black 2.5pt double; text-align: right" title="Fair value of liabilities">241,681</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

249963

6775220

7025183

-8282

-1485795

-1494077

-5289425 -5289425

241681

The key inputs into the Monte Carlo simulation as of January 14, 2021 and June 30, 2021 were as follows: Schedule of Key Inputs into Monte Carlo Simulation <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Initial Measurement)</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font-weight: bold">Inputs</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">January 14, 2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2021</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 58%; text-align: left">Risk-free interest rate</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPercent_c20210113__20210114_zyXpxvc4IFoj" style="width: 18%; text-align: right" title="Risk-free interest rate">0.60</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_pid_dp_uPercent_c20210101__20210630_zuZgn2KW7fyf" style="width: 18%; text-align: right" title="Risk-free interest rate">0.90</td> <td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Expected term remaining (years)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5.67</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5.19</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Expected volatility</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">24.2</td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">19.8</td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Stock price</td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98F_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20210114_zCXVmjVSChDc" style="text-align: right" title="Stock price">9.41</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left">$</td> <td id="xdx_98B_eus-gaap--SharePrice_iI_pid_uUSDPShares_c20210630_zC28cdJprtw9" style="text-align: right" title="Stock price">9.96</td> <td style="text-align: left"> </td></tr> </table>

0.0060

0.0090

P5Y8M1D

P5Y2M8D

0.242

0.198

9.41

9.96

Note 10 — Subsequent Events None.

84836

2258

87094

235111

322205

156201

150000

306201

0.0001

1000000

0.0001

50000000

2875000

288

24712

-8996

16004

322205

343125

31875

8996

-8996

2500000

-0.00

343125

31875

2875000

288

24712

25000

-8996

2875000

288

24712

-8996

16004

2875000

288

24712

-8996

16004

343125

31875

-8996

2558

1222

-10032

25000

150000

80132

94868

84836

154979

<p id="xdx_802_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_zG025ynjKrSi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Note 1 — Organization and Business Operations Big Cypress Acquisition Corp. (the “Company”) is a newly organized blank check company incorporated in Delaware on November 12, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses (“Business Combination”). The Company has not selected any specific business combination target and the Company has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target with respect to the Business Combination. As of December 31, 2020, the Company had not commenced any operations. All activity for the period from November 12, 2020 (inception) through December 31, 2020 relates to the Company’s formation and preparation for the Initial Public Offering (“IPO”) as described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on cash and cash equivalents from the proceeds derived from the Initial Public Offering as described below. The Company has selected December 31 as its fiscal year end. The Company’s sponsor is Big Cypress Holdings LLC, a Delaware limited liability company (the “Sponsor”). Subsequent to December 31, 2020, the registration statement for the Company’s IPO was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on January 11, 2021 (the “Effective Date”). On January 14, 2021, the Company consummated the IPO of 11,500,000 units (the “Units”), which included the full exercise by the underwriters of the over-allotment option to purchase an additional <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_pdd" title="Units issued during the period, shares">1,500,000 Units, at $10.00 per Unit, generating gross proceeds of $115,000,000, which is discussed in Note 3. Simultaneously with the closing of the IPO, the Company consummated the sale of <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210113__20210114__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_pdd" title="Sale of units">417,200 units (the “Placement Units”), at a price of $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_c20210114__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_pdd" title="Unit issued price">10.00 per unit, generating gross proceeds of $<span id="xdx_90D_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_c20210113__20210114__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_pp0p0" title="Proceeds from sale of units">4,172,000, which is discussed in Note 4. Each Unit consists of one share of common stock, and one-half redeemable warrant to purchase one share of common stock at a price of $11.50 per whole share. Transaction costs of the IPO amounted to $6,038,360 consisting of $1,529,500 of underwriting fee, $4,220,500 of deferred underwriting fee, and $288,360 of other offering costs (see Note 8). Following the closing of the IPO on January 14, 2021, $116,150,000 ($10.10 per Unit) from the net offering proceeds of the sale of the Units in the IPO and the sale of the Placement Units was placed in a trust account (the “Trust Account”) and invested in U.S. government securities, within the meaning set forth in Section 2(a)(16) of the Investment Company Act, with a maturity of 180 days or less or in any open-ended investment company that holds itself out as a money market fund meeting the conditions of Rule 2a-7 of the Investment Company Act, as determined by the Company. Except with respect to interest earned on the funds held in the Trust Account that may be released to the Company to pay its franchise and income tax obligations (less up to $100,000 of interest to pay dissolution expenses), the proceeds from this IPO and the sale of the Placement Units will not be released from the trust account until the earliest of (a) the completion of the Company’s initial business combination, (b) the redemption of any public shares properly submitted in connection with a stockholder vote to amend the Company’s amended and restated certificate of incorporation, and (c) the redemption of the Company’s public shares if the Company is unable to complete the initial business combination within 15 months (or up to 21 months) from the closing of this IPO, subject to applicable law. The proceeds deposited in the trust account could become subject to the claims of the Company’s creditors, if any, which could have priority over the claims of the Company’s public stockholders. The Company will provide its public stockholders with the opportunity to redeem all or a portion of their public shares upon the completion of the initial business combination either (i) in connection with a stockholder meeting called to approve the initial business combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a proposed initial business combination or conduct a tender offer will be made by the Company, solely in its discretion. The stockholders will be entitled to redeem their shares for a pro rata portion of the amount then on deposit in the Trust Account (initially approximately $10.10 per share, plus any pro rata interest earned on the funds held in the Trust Account and not previously released to the Company to pay its tax obligations). The shares of common stock subject to redemption will be recorded at a redemption value and classified as temporary equity upon the completion of the IPO, in accordance with Accounting Standards Codification (“ASC”) Topic 480 “Distinguishing Liabilities from Equity.” In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 upon such consummation of a Business Combination and, if the Company seeks stockholder approval, a majority of the issued and outstanding shares voted are voted in favor of the Business Combination. The Company will have 15 months (or up to 21 months) from the closing of the IPO to consummate a Business Combination (the “Combination Period”). However, if the Company is unable to complete a Business Combination within the Combination Period, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the trust account, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company to pay its franchise and income taxes, divided by the number of then outstanding public shares, subject to applicable law and as further described in registration statement, and then seek to dissolve and liquidate. The Sponsor, officers and directors have agreed to (i) waive their redemption rights with respect to their founder shares and placement shares in connection with the completion of the initial business combination, (ii) waive their redemption rights with respect to their founder shares and placement shares in connection with a stockholder vote to approve an amendment to the Company’s amended and restated certificate of incorporation, and (iii) waive their rights to liquidating distributions from the trust account with respect to their founder shares and placement shares if the Company fails to complete the initial business combination within the Combination Period. The Company’s Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party for services rendered or products sold to the Company, or a prospective target business with which the Company has entered into a written letter of intent, confidentiality or similar agreement or business combination agreement, reduce the amount of funds in the trust account to below the lesser of (i) $10.00 per public share and (ii) the actual amount per public share held in the trust account as of the date of the liquidation of the trust account, if less than $10.00 per share due to reductions in the value of the trust assets, less taxes payable, provided that such liability will not apply to any claims by a third party or prospective target business who executed a waiver of any and all rights to the monies held in the trust account (whether or not such waiver is enforceable) nor will it apply to any claims under the Company’s indemnity of the underwriters of this offering against certain liabilities, including liabilities under the Securities Act. However, the Company has not asked its Sponsor to reserve for such indemnification obligations, nor has the Company independently verified whether its Sponsor has sufficient funds to satisfy its indemnity obligations and believe that the Company’s Sponsor’s only assets are securities of the Company. Therefore, the Company cannot assure that its Sponsor would be able to satisfy those obligations. Liquidity and Capital Resources As of December 31, 2020, the Company had $84,836 in cash and working capital deficit of $219,107 (excluding deferred offering costs). The Company’s liquidity needs up to December 31, 2020 had been satisfied through a capital contribution from the Sponsor of $25,000 (see Note 5) for the founder shares and the loan under an unsecured promissory note from the Sponsor of $150,000 (see Note 5). Subsequent to December 31, 2020, on January 14, 2021, simultaneous with the consummation of the IPO, the net proceeds from the consummation of the Private Placement not held in Trust were deposited into the Company’s operating bank account (see Note 8). As of January 14, 2021, the Company had approximately $1.2 million in its operating bank account, and working capital of approximately $1.2 million. In addition, in order to finance transaction costs in connection with a Business Combination, the Company’s Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, provide the Company Working Capital Loans (see Note 5). To date, there were no amounts outstanding under any Working Capital Loans. Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Risks and Uncertainties Management continuing to evaluate the impact of the COVID-19 pandemic and has concluded that while it is reasonably possible that it could have a negative effect on the Company’s financial position, results of its operations and/or search for a target company, the specific impact is not readily determinable as of the date of these financial statements. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

11500000

1500000

10.00

115000000

417200

10.00

4172000

Each Unit consists of one share of common stock, and one-half redeemable warrant to purchase one share of common stock at a price of $11.50 per whole share.

11.50

6038360

1529500

4220500

288360

116150000

10.10 The Company will have 15 months (or up to 21 months) from the closing of the IPO to consummate a Business Combination (the “Combination Period”). However, if the Company is unable to complete a Business Combination within the Combination Period, the Company will redeem 100% of the outstanding public shares for a pro rata portion of the funds held in the trust account, equal to the aggregate amount then on deposit in the trust account including interest earned on the funds held in the trust account and not previously released to the Company to pay its franchise and income taxes, divided by the number of then outstanding public shares, subject to applicable law and as further described in registration statement, and then seek to dissolve and liquidate.

84836

219107

25000

150000

1200000

Note 2 — Significant Accounting Policies Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”). Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020. Deferred Offering Costs Deferred offering costs consist of legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO and that will be charged to stockholders’ equity upon the completion of the IPO. Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. Net Loss Per Common Stock Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 375,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Note 5 and Note 8). As a result of the underwriter’s election to fully exercise their over-allotment option on January 14, 2021, the <span id="xdx_90A_ecustom--StockIssuedDuringPeriodSharesStockOptionExercised_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zibeFIloooO8" title="Shares exercised during the period">375,000 Founder Shares are no longer subject to forfeiture (see Note 8). At December 31, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per common share is the same as basic loss per common share for the period presented. Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The deferred tax assets were deemed to be de minimus as of December 31, 2020. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income tax examinations by major taxing authorities since inception. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The provision for income taxes was deemed to be de minimus for the period from November 12, 2020 (inception) through December 31, 2020. Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Basis of Presentation The accompanying financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“US GAAP”) and pursuant to the rules and regulations of the U.S. Securities and Exchange Commission (the “SEC”).

Emerging Growth Company Status The Company is an “emerging growth company,” as defined in Section 2(a) of the Securities Act, as modified by the Jumpstart our Business Startups Act of 2012, (the “JOBS Act”), and it may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies including, but not limited to, not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in its periodic reports and proxy statements, and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. Further, Section 102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that a company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard. This may make comparison of the Company’s financial statements with another public company which is neither an emerging growth company nor an emerging growth company which has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Use of Estimates The preparation of financial statements in conformity with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

Cash and Cash Equivalents The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not have any cash equivalents as of December 31, 2020.

Deferred Offering Costs Deferred offering costs consist of legal, accounting and other expenses incurred through the balance sheet date that are directly related to the IPO and that will be charged to stockholders’ equity upon the completion of the IPO.

Fair Value of Financial Instruments The fair value of the Company’s assets and liabilities approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

Net Loss Per Common Stock Net loss per share is computed by dividing net loss by the weighted average number of shares of common stock outstanding during the period, excluding common stock subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 375,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters (see Note 5 and Note 8). As a result of the underwriter’s election to fully exercise their over-allotment option on January 14, 2021, the <span id="xdx_90A_ecustom--StockIssuedDuringPeriodSharesStockOptionExercised_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zibeFIloooO8" title="Shares exercised during the period">375,000 Founder Shares are no longer subject to forfeiture (see Note 8). At December 31, 2020, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per common share is the same as basic loss per common share for the period presented.

375000

Income Taxes The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized. The deferred tax assets were deemed to be de minimus as of December 31, 2020. ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. There were no unrecognized tax benefits and no amounts accrued for interest and penalties as of December 31, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company has identified the United States as its only “major” tax jurisdiction. The Company is subject to income tax examinations by major taxing authorities since inception. These potential examinations may include questioning the timing and amount of deductions, the nexus of income among various tax jurisdictions and compliance with federal and state tax laws. The Company’s management does not expect that the total amount of unrecognized tax benefits will materially change over the next twelve months. The provision for income taxes was deemed to be de minimus for the period from November 12, 2020 (inception) through December 31, 2020.

Concentration of Credit Risk Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the federal depository insurance coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

250000

Recent Accounting Pronouncements Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on the Company’s financial statements.

Note 3 — Initial Public Offering On January 14, 2021, the Company sold 11,500,000 at a purchase price of $10.00 per Unit, which includes the full exercise by the underwriters of the over-allotment option to purchase an additional <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zRnDepV5YzDi" title="Units issued during the period, shares">1,500,000 Units (see Note 8). Each Unit consists of one share of common stock, and one-half warrant to purchase one share of common stock (“Public Warrant”). Each Public Warrant entitles the holder thereof to purchase one share of common stock at a price of $11.50 per share, subject to adjustment. Each warrant will become exercisable on the later of 30 days after the completion of the initial Business Combination or 12 months from the closing of this offering and will expire five years after the completion of the initial Business Combination, or earlier upon redemption or liquidation. (see Note 7).

11500000

10.00

1500000

11.50

Note 4 — Private Placement Simultaneously with the closing of the IPO, the Sponsor purchased an aggregate of <span id="xdx_90B_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20201112__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_zMRfQU1Fropg" title="Sale of units">417,200 Placement Units, at a price of $<span id="xdx_900_eus-gaap--SharesIssuedPricePerShare_iI_c20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_zGfoLGu22Htd" title="Unit issued price">10.00 per Placement Unit, for an aggregate purchase price of $<span id="xdx_906_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pp0p0_c20201112__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_zablzaefmw97" title="Proceeds from sale of units">4,172,000, in a private placement. A portion of the proceeds from the private placement was added to the proceeds from the IPO held in the Trust Account (see Note 8). Each Placement Unit was identical to the Units sold in the IPO, except for the placement warrants (“Placement Warrants”) (see Note 7). If the Company does not complete its initial business combination within 15 months (or up to 21 months) from the closing of this IPO, the proceeds from the sale of the Placement Units held in the trust account will be used to fund the redemption of its public shares (subject to the requirements of applicable law) and the Placement Warrants will expire worthless.

417200

10.00

4172000

Note 5 — Related Party Transactions Founder Shares On November 12, 2020, the Company issued <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201110__20201113__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zCA5J84AkCWl" title="Units issued during the period, shares">2,156,250 shares of common stock to the Sponsor for $<span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20201110__20201113__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zR9oX3fZwTR4" title="Stock issued during the period">25,000 in cash, or approximately $<span id="xdx_901_eus-gaap--SharesIssuedPricePerShare_iI_c20201113__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zmncQNmaZz7d" title="Shares issued price per share">0.012 per share, in connection with formation. On December 7, 2020, the Sponsor forfeited <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20201206__20201207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_pdd" title="Shares forfeited during the period">161,719 founder shares to the Company and Ladenburg Thalmann & Co. Inc., the representative of the underwriters, and certain of its employees (“Ladenburg”) purchased from the Company an aggregate of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201206__20201207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pdd" title="Units issued during the period, shares">161,719 representative shares at an average purchase price of approximately $<span id="xdx_90F_eus-gaap--SharesIssuedPricePerShare_c20201207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pdd" title="Shares issued price per share">0.012 per share, for an aggregate purchase price of $<span id="xdx_903_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20201206__20201207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pp0p0" title="Stock issued during the period">1,875. On January 3, 2021, the Company effected a stock dividend of 1/3 of a share of common stock for every share of common stock outstanding, resulting in an aggregate of 2,875,000 founder shares outstanding (including up to <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210102__20210103__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_pdd" title="Shares forfeited during the period">375,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part). As a result of the underwriters’ election to fully exercise of their over-allotment option on January 14, 2021, the <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_pdd" title="Shares exercised during the period">375,000 shares were no longer subject to forfeiture (see Note 7). On January 4, 2021, the Sponsor forfeited <span id="xdx_90F_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zv1bTheYviLi" title="Shares forfeited during the period">28,750 founder shares to the Company and Ladenburg and certain of its employees purchased from the Company an aggregate of <span id="xdx_90D_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pdd" title="Units issued during the period, shares">28,750 representative shares at an average purchase price of approximately $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_c20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pdd" title="Shares issued price per share">0.008 per share, for an aggregate purchase price of $<span id="xdx_906_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zMOJqHk8nFi2" title="Stock issued during the period">230. As a result, the Sponsor currently own <span id="xdx_90F_ecustom--SharesOwned_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_pdd" title="Shares owned">2,630,625 shares (see Note 7). All shares of common stock and associated amounts have been retroactively restated as disclosed in Note 7. <span id="xdx_906_ecustom--AgreementDescription_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zfGtSR2TrYll" title="Agreement description">The Sponsor has agreed not to transfer, assign or sell 50% of its founder shares until the earlier to occur of (A) six months after the completion of the Company’s initial business combination or (B) the date the last sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial business combination, and the remaining 50% of the founder shares until six months after the completion of the Company’s initial business combination, or earlier, if, in either case, subsequent to the Company’s initial business combination, the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property. Representative Shares On December 7, 2020, the Sponsor forfeited <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pid_uShares_c20211206__20211207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zdSLL818hh3k">161,719 founder shares to the Company and Ladenburg and certain of its employees purchased from the Company an aggregate of <span id="xdx_904_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_pid_uShares_c20211206__20211207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zFpuXKIw0caj">161,719 representative shares at an average purchase price of approximately $<span id="xdx_905_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20211207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zjFXSH52dOHi">0.012 per share, for an aggregate purchase price of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20211206__20211207__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zeTEwmcorm96">1,875. On January 4, 2021, the Sponsor forfeited <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_pid_uShares_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zpNUmMX2cOne">28,750 founder shares to the Company and Ladenburg and certain of its employees purchased from the Company an aggregate of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_pid_uShares_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zl5xmKoxFXs4">28,750 representative shares at an average purchase price of approximately $<span id="xdx_90A_eus-gaap--SharesIssuedPricePerShare_iI_pid_uUSDPShares_c20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zCVCZHx6NDqj">0.008 per share, for an aggregate purchase price of $<span id="xdx_909_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zbBrWPxDpEsk">230. Following the 1/3 common stock dividend effected January 3, 2020 (as described herein), Ladenburg and certain of its employees now hold an aggregate of <span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_c20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pdd" title="Common stock, shares outstanding">244,375 representative shares (of which up to <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210102__20210103__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pdd" title="Shares forfeited during the period">31,875 were subject to forfeiture). As a result of the underwriters’ election to fully exercise of their over-allotment option, the <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_c20210102__20210103__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pdd" title="Shares exercised during the period">31,875 shares were no longer subject to forfeiture (see Note 8). All shares of common stock and associated amounts have been retroactively restated as disclosed in Note 8. Ladenburg and certain of its employees have entered into a subscription agreement with the Company, pursuant to which they have agreed to (i) waive their redemption rights with respect to their representative shares, as applicable, and public shares in connection with the completion of our initial business combination, (ii) waive their redemption rights with respect to their representative shares, as applicable, (iii) waive their rights to liquidating distributions from the trust account with respect to their representative shares if the Company fails to complete the initial business combination within the Combination Period. Promissory Note — Related Party On November 19, 2020, Company issued an unsecured promissory note to the Sponsor for an aggregate of up to $<span id="xdx_90A_eus-gaap--UnsecuredDebt_iI_pp0p0_c20201119__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--RangeAxis__srt--MaximumMember_zG3F5Qtl1Eo5" title="Unsecured promissory note">250,000 to cover expenses related to the IPO. <span id="xdx_900_eus-gaap--DebtInstrumentMaturityDateDescription_c20201117__20201119__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zZY9gHqLirW9" title="Debt instrument maturity date">This loan is non-interest bearing and payable on the earlier of March 31, 2021 or the completion of the IPO. As of December 31, 2020, the Company has drawn down $150,000 under the promissory note. On January 14, 2021, the Company paid the balance on the note from the proceeds of the IPO (see Note 8). Related Party Loans In order to finance transaction costs in connection with a Business Combination, the Sponsor or an affiliate of the Sponsor or certain of the Company’s officers and directors may, but are not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company would repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans would be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of the working capital held outside the Trust Account to repay the Working Capital Loans but no proceeds from the Trust Account would be used to repay the Working Capital Loans. Up to $1,500,000 of such Working Capital Loans may be convertible into units at a price of $10.00 per unit at the option of the lender, upon consummation of the Company’s Initial Business Combination. The units would be identical to the Placement Units. At January 14, 2021, no Working Capital Loans were outstanding. Administrative Service Fee The Company has agreed to pay an affiliate of the Company’s Sponsor a monthly fee of an aggregate of $10,000 for office space, utilities and secretarial and administrative support. Upon completion of the Company’s Business Combination or its liquidation, the Company will cease paying these monthly fees. As of December 31, 2020, the Company has recorded $7,742 in service fee expense.

2156250

25000

0.012

161719

0.012

1875

2875000

375000

28750

0.008

230

161719

0.012

1875

28750

0.008

230

244375

31875

250000

This loan is non-interest bearing and payable on the earlier of March 31, 2021 or the completion of the IPO.

150000

10000

7742

Note 6 — Commitments and Contingencies Underwriting Agreement The underwriter had a 45-day option from the date of the IPO to purchase up to an aggregate of <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember__us-gaap--TypeOfArrangementAxis__custom--UnderwritingAgreementMember_zkUDdts5u7d" title="Units issued during the period, shares">1,500,000 additional Units at the public offering price less the underwriting commissions to cover over-allotments, if any. On January 14, 2021, the underwriter fully exercised its over-allotment option (see Note 8). The underwriter was entitled to a cash underwriting fee of <span id="xdx_90A_ecustom--CashUnderwritingFeePercentage_pid_dp_uPercent_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_zqZtqAmSMlke">1.33% of the gross proceeds of the IPO and, upon consummation of the IPO on January 14, 2021, was paid an aggregate of $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_z7jAe07dLDIh">1,529,500. The underwriters are entitled to deferred underwriting fee of <span id="xdx_90D_ecustom--DeferredUnderwritingFeePercentage_pid_dp_uPercent_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_znVfyPnwtgM6">3.67% of the gross proceeds of the IPO, or $<span id="xdx_90D_ecustom--ProceedsFromDeferredUnderwriting_pp0p0_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember__srt--TitleOfIndividualAxis__custom--UnderwritersMember_z8RH3sgDEvOi">4,220,500 in the aggregate. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement. Registration Rights The holders of the founder shares, representative shares, placement units, and units that may be issued upon conversion of working capital loans will have registration rights to require the Company to register a sale of any of its securities held by them pursuant to a registration rights agreement to be signed prior to or on the effective date of this offering. These holders will be entitled to make up to three demands, excluding short form registration demands, that the Company registers such securities for sale under the Securities Act. In addition, these holders will have “piggy-back” registration rights to include their securities in other registration statements filed by the Company. The Company will bear the expenses incurred in connection with the filing of any such registration statements.

1500000

0.0133

1529500

0.0367 4220500

Note 7 — Stockholders’ Equity Preferred Stock — The Company is authorized to issue a total of 1,000,000 preferred shares at par value of $0.0001 each. At December 31, 2021, there were no shares of preferred stock issued or outstanding. Common Stock — The Company is authorized to issue a total of 50,000,000 share of common stock at par value of $0.0001 each. At November 20, 2020, the Company issued 2,156,250 common shares to its initial stockholders for $25,000, or approximately $0.012 per share. On December 7, 2020, the Sponsor forfeited <span id="xdx_906_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20201206__20201207__srt--TitleOfIndividualAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_pdd" title="Shares forfeited during the period">161,719 founder shares to the Company and Ladenburg and certain of its employees purchased from the Company an aggregate of <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20201206__20201207__srt--TitleOfIndividualAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pdd" title="Units issued during the period, shares">161,719 representative shares at an average purchase price of approximately $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_c20201207__srt--TitleOfIndividualAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pdd" title="Shares issued price per share">0.012 per share, for an aggregate purchase price of $<span id="xdx_907_eus-gaap--StockIssuedDuringPeriodValueNewIssues_c20201206__20201207__srt--TitleOfIndividualAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_pp0p0" title="Stock issued during the period">1,875. On January 3, 2021, the Company effected a stock dividend of 1/3 of a share of common stock for every share of common stock outstanding, resulting in an aggregate of 2,875,000 founder shares outstanding (including up to <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210102__20210103__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_z7hnYpNBkYvh" title="Shares forfeited during the period">375,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part). On January 4, 2021, the Sponsor forfeited <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_z2l20AqArype" title="Shares forfeited during the period">28,750 founder shares to the Company and Ladenburg and certain of its employees purchased from the Company an aggregate of <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zOpkn9tHRp95" title="Units issued during the period, shares">28,750 representative shares at an average purchase price of approximately $<span id="xdx_903_eus-gaap--SharesIssuedPricePerShare_iI_c20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zfegzLjWmkz7" title="Shares issued price per share">0.008 per share, for an aggregate purchase price of $<span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_ztYjnlb6exYa" title="Stock issued during the period">230. As a result, the Sponsor currently own 2,630,625 shares and Ladenburg and certain of its employees currently own <span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zbuBH7fDJA37" title="Common stock, shares outstanding">244,375 representative shares (including up to <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_pdd" title="Shares forfeited during the period">343,125 and <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember_pdd" title="Shares forfeited during the period">31,875 shares, respectively, that were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part). As a result of the underwriters’ election to fully exercise of their over-allotment option on January 14, 2021, the 375,000 shares were no longer subject to forfeiture (see Note 8). All shares of common stock and associated amounts have been retroactively restated. The Company’s initial stockholder has agreed not to transfer, assign or sell 50% of its founder shares until the earlier to occur of (A) six months after the completion of the Company’s initial business combination or (B) the date the last sale price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial business combination, and not to transfer, assign or sell the remaining 50% of the founder shares until six months after the completion of the Company’s initial business combination, or earlier, if, in either case, subsequent to the Company’s initial business combination, the date on which the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all of its stockholders having the right to exchange their shares of common stock for cash, securities or other property. Any permitted transferees will be subject to the same restrictions and other agreements of the Company’s initial stockholders with respect to any founder shares. Warrants — Each whole warrant entitles the holder to purchase one share of the Company’s common stock at a price of $11.50 per share, subject to adjustment as discussed herein. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s Sponsor or its affiliates, without taking into account any founder shares held by the Company’s Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price. The warrants will become exercisable on the later of 12 months from the closing of this offering or 30 days after the completion of its initial business combination, and will expire five years after the completion of the Company’s initial business combination, at 5:00 p.m., New York City time, or earlier upon redemption or liquidation. The Company will not be obligated to deliver any shares of common stock pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities Act with respect to the shares of common stock underlying the warrants is then effective and a prospectus is current. No warrant will be exercisable and the Company will not be obligated to issue shares of common stock upon exercise of a warrant unless common stock issuable upon such warrant exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In no event will the Company be required to net cash settle any warrant. In the event that a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the share of common stock underlying such unit. Once the warrants become exercisable, the Company may call the warrants for redemption: <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">in whole and not in part;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">at a price of $0.01 per warrant;</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">upon not less than 30 days’ prior written notice of redemption (the “30-day redemption period”) to each warrant holder; and</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif">●</td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">if, and only if, the reported last sale price of the common stock equals or exceeds $18.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending three business days before the Company send the notice of redemption to the warrant holders.</td></tr> </table> The Placement Warrants will be identical to the Public Warrants underlying the Units being sold in the IPO, except that the Placement Warrants and the common stock issuable upon the exercise of the Placement Warrants will not be transferable, assignable or saleable until after the completion of a Business Combination, subject to certain limited exceptions. Additionally, the Placement Warrants will be exercisable on a cashless basis and be non-redeemable so long as they are held by the initial purchasers or their permitted transferees. If the Placement Warrants are held by someone other than the initial purchasers or their permitted transferees, the Placement Warrants will be redeemable by the Company and exercisable by such holders on the same basis as the Public Warrants. If the Company calls the warrants for redemption as described above, the management will have the option to require any holder that wishes to exercise its warrant to do so on a “cashless basis.” If the management takes advantage of this option, all holders of warrants would pay the exercise price by surrendering their warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the excess of the “fair market value” (defined below) over the exercise price of the warrants by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the common stock for the 10 trading days ending on the third trading day prior to the date on which the notice of redemption is sent to the holders of warrants

1000000

0.0001

50000000

0.0001

2156250

25000

0.012

161719

0.012

1875

2875000

375000

28750

0.008

230

2630625

244375

343125

31875

375000

11.50

In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of its initial business combination at an issue price or effective issue price of less than $9.20 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors and, in the case of any such issuance to the Company’s Sponsor or its affiliates, without taking into account any founder shares held by the Company’s Sponsor or its affiliates, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial business combination on the date of the consummation of the initial business combination (net of redemptions), and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates the initial business combination (such price, the “Market Value”) is below $9.20 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described below under “Redemption of warrants” will be adjusted (to the nearest cent) to be equal to 180% of the higher of the Market Value and the Newly Issued Price.

0.01

Note 8 — Subsequent Events The Company evaluated subsequent events and transactions that occurred after the balance sheet date up to the date that the financial statements were issued. Based upon this review, other than as described below, the Company did not identify any subsequent events that would have required adjustment or disclosure in the financial statements. On January 3, 2021, the Company effected a stock dividend of 1/3 of a share of common stock for every share of common stock outstanding, resulting in an aggregate of 2,875,000 founder shares outstanding (including up to <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210102__20210103__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_zQMBoqzSnDga" title="Shares forfeited during the period">375,000 shares subject to forfeiture to the extent that the underwriters’ over-allotment is not exercised in full or in part). On January 4, 2021, the Sponsor forfeited <span id="xdx_908_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__us-gaap--StatementEquityComponentsAxis__custom--FounderSharesMember_z5yeGNLrcvr1" title="Shares forfeited during the period">28,750 founder shares to the Company and Ladenburg and certain of its employees purchased from the Company an aggregate of <span id="xdx_905_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zvLTdZXHiqL" title="Units issued during the period, shares">28,750 representative shares at an average purchase price of approximately $<span id="xdx_904_eus-gaap--SharesIssuedPricePerShare_iI_c20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zRjpk0tX2hNc" title="Shares issued price per share">0.008 per share, for an aggregate purchase price of $<span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodValueNewIssues_pp0p0_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zpMyhWJQOCO4" title="Stock issued during the period">230. As a result, the Sponsor currently own 2,630,625 shares and Ladenburg and certain of its employees currently own <span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_iI_c20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember__us-gaap--StatementEquityComponentsAxis__custom--RepresentativeSharesMember_zawv9UFuQifi" title="Common stock, shares outstanding">244,375 representative shares (including up to <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember_zOlpeaskbjcj" title="Shares forfeited during the period">343,125 and <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesShareBasedCompensationForfeited_c20210102__20210104__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LadenburgAndCertainEmployeesMember_zLlhuTe2E8oa" title="Shares forfeited during the period">31,875 shares, respectively, that were subject to forfeiture to the extent that the underwriters’ over-allotment was not exercised in full or in part). As a result of the underwriters’ election to fully exercise of their over-allotment option on January 14, 2021, the 375,000 shares were no longer subject to forfeiture All shares of common stock and associated amounts have been retroactively restated. On January 14, 2021, the Company the Company consummated the IPO of 11,500,000 units (the “Units”), which included the full exercise by the underwriters of the over-allotment option to purchase an additional <span id="xdx_90C_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_zE0zBNgzVgR" title="Units issued during the period, shares">1,500,000 Units, at $10.00 per Unit, generating gross proceeds of $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--OverAllotmentOptionMember_z9mO9roDKiW1" title="Proceeds from IPO">115,000,000. Simultaneously with the closing of the IPO, the Company consummated the sale of <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20210113__20210114__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_zmSjzkoLQ6Vj" title="Sale of units">417,200 units (the “Placement Units”), at a price of $<span id="xdx_902_eus-gaap--SharesIssuedPricePerShare_iI_c20210114__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_zX3foFSBlarh" title="Shares issued price per share">10.00 per unit, for an aggregate purchase price of $<span id="xdx_90E_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pp0p0_c20210113__20210114__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--SponsorMember__srt--StatementScenarioAxis__custom--ClosingIPOMember_zP7ZwmQUWhM1" title="Proceeds from sale of units">4,172,000, in a private placement. Transaction costs of the IPO amounted to $6,038,360 consisting of $1,529,500 of underwriting fee, $4,220,500 of deferred underwriting fee, and $288,360 of other offering costs. On January 14, 2021, the Company paid the $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfDebt_pp0p0_c20210113__20210114__us-gaap--SubsidiarySaleOfStockAxis__us-gaap--IPOMember_zZn4dxzsQ3Sj" title="Proceeds from issuance of promissory note to related party">150,000 balance on the promissory note from the proceeds of the IPO.

2875000

375000

28750

0.008

230

2630625

244375

343125

31875

375000

11500000

1500000

10.00

115000000

417200

10.00

4172000

6038360

1529500

4220500

288360

150000

Excludes an aggregate of 10,117,574 shares subject to possible redemption. Includes up to 343,125 founder shares subject to forfeiture by the Sponsor and up to 31,875 representative shares held by Ladenburg and certain of its employees subject to forfeiture if over-allotment option was not exercised in full or in part by the underwriters (see Note 5 and Note 8). As a result of the underwriter’s election to fully exercise their over-allotment option on January 14, 2021, the founder shares and representative shares are no longer subject to forfeiture (see Note 8). Excludes up to 343,125 founder shares subject to forfeiture by the Sponsor and up to 31,875 representative shares held by Ladenburg and certain of its employees subject to forfeiture if over-allotment option was not exercised in full or in part by the underwriters (see Note 5 and Note 8). As a result of the underwriter’s election to fully exercise their over-allotment option on January 14, 2021, the founder shares and representative shares are no longer subject to forfeiture (see Note 8). Includes up to 343,125 founder shares subject to forfeiture by the Sponsor and up to 31,875 representative shares held by Ladenburg and certain of its employees subject to forfeiture if over-allotment option was not exercised in full or in part by the underwriters (see Note 5 and Note 8). As a result of the underwriter’s election to fully exercise their over-allotment option on January 14, 2021, the founder shares and representative shares are no longer subject to forfeiture (see Note 8).